Guerbet symposium looks at the role of AI in oncology imaging

As a long-standing partner of ECR, contrast agent and medical imaging solutions provider Guerbet is contributing to the programme under this year’s theme Next Generation Radiology.

With its MRI expertise, Guerbet will unveil advances in diagnostic imaging and a disruptive AI programme. Guerbet says its presence at the congress demonstrates its commitment to redefining medical imaging standards.

Guerbet is positioning itself as a main player in AI in radiology

The AI programme will explore Guerbet’s advances in the field, highlighting crucial topics such as MRI detection of prostate cancer, the use of deep learning-based algorithms to detect focal liver lesions, and a new approach with AI for pancreatic cancer detection.

Below you can find the details for Guerbet’s symposium at ECR 2024:

AI symposium
March 1, 2024, 12:30 pm – 13:30 pm, Central European Time (CET)
Oncological imaging: how to improve detection with AI
Moderator: Professor Carlo Quattrocchi, Trento University, Trento/Italy
Speakers: Anindo Saha, Radboud University Medical Center, Nijmegen, the Netherlands; Professor Maxime Ronot, Beaujon University Hospital, Clichy, France and Clément Abi-Nader, AI medical imaging scientist at Guerbet, France.

We look forward to seeing you at ECR 2024!

“We are incredibly excited to welcome Guerbet as a key partner at this year’s congress. Their approach to AI and innovation is perfectly aligned with this year’s congress theme of Next Generation Radiology,” said Carlo Catalano, ECR 2024 congress president.

Visit Guerbet at ECR on stand 222.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated ECR conference page to find out more.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more